首页 | 本学科首页   官方微博 | 高级检索  
     

消癌解毒方诱导人肝癌SMMC-7721细胞miRNA表达变化
引用本文:徐力立,陈慧,吴铭杰,陈海彬,李文婷,沈政洁,上官端丹,董凡,李林晚,周红光. 消癌解毒方诱导人肝癌SMMC-7721细胞miRNA表达变化[J]. 中国实验方剂学杂志, 2018, 24(7): 89-94
作者姓名:徐力立  陈慧  吴铭杰  陈海彬  李文婷  沈政洁  上官端丹  董凡  李林晚  周红光
作者单位:南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,张家港市第一人民医院, 江苏 张家港 215600,句容市中医院, 江苏 句容 212400,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023,南京中医药大学 江苏省中医药防治肿瘤协同创新中心, 南京 210023;江苏省中医院, 南京 210029
基金项目:国家自然科学基金面上项目(81473608);江苏省大学生创新训练计划项目(201610315042Z,201710315060Y)
摘    要:目的:探讨消癌解毒方对人肝癌SMMC-7721细胞增殖及微小核糖核酸(microRNA,miR)-25-3p,miR-29a-5p,miR-122-3p,miR-124-3p,miR-182-5p表达谱的影响。方法:将12只雄性大耳白兔随机分为4组,分别为消癌解毒方高、中、低剂量(15.12,7.56,3.78 g·kg-1)组和空白组,各组分别给予消癌解毒方及生理盐水灌胃4 d。4 d后于颈动脉中取血清并配制培养基。用消癌解毒方(15.12,7.56,3.78 g·kg-1)含药血清及空白血清的培养基处理人肝癌细胞株SMMC-7721,噻唑蓝(MTT)比色法检测肿瘤细胞增殖活性、实时荧光定量逆转录聚合酶链式反应(Real-time polymerase chain reaction,Real-time PCR)法验证人肝癌细胞SMMC-7721中miR-25-3p,miR-29a-5p,miR-122-3p,miR-124-3p和miR-182-5p的表达水平。结果:经过12,24,48 h后,消癌解毒方(15.12,7.56,3.78 g·kg-1)含药血清对人肝癌SMMC-7721细胞的增殖均存在抑制作用。随着消癌解毒方含药血清浓度的增加,其对人肝癌细胞SMMC-7721细胞增殖的抑制率也相应增加。其中高剂量组含药血清的抑制效果最好,其干预12,48 h的吸光度A较同期空白组明显降低(P0.05)。高剂量组干预24 h A比同期空白组显著降低(P0.01),该组抑制率为42.86%。Real-time PCR证实消癌解毒方(15.12,7.56,3.78 g·kg-1)含药血清的培养基能诱导miR-25-3p,miR-182-5p表达下调,诱导miR-29a-5p,miR-122-3p,miR-124-3p表达上调。且高剂量组的调控作用较空白组更显著(P0.01)。结论:消癌解毒方可能通过诱导miRNA表达谱的改变而参与抑制人肝癌细胞SMMC-7721增殖作用,但其具体机制仍有待进一步研究。

关 键 词:癌毒  消癌解毒方  肝癌SMMC-7721细胞  微小核糖核酸  抑制增殖
收稿时间:2017-07-31

miRNA Expression of SMMC-7721 Cell Induced by Xiaoai Jiedu Formula
XU Li-li,CHEN Hui,WU Ming-jie,CHEN Hai-bin,LI Wen-ting,SHEN Zheng-jie,SHANGGUAN Duan-dan,DONG Fan,LI Lin-wan and ZHOU Hong-guang. miRNA Expression of SMMC-7721 Cell Induced by Xiaoai Jiedu Formula[J]. China Journal of Experimental Traditional Medical Formulae, 2018, 24(7): 89-94
Authors:XU Li-li  CHEN Hui  WU Ming-jie  CHEN Hai-bin  LI Wen-ting  SHEN Zheng-jie  SHANGGUAN Duan-dan  DONG Fan  LI Lin-wan  ZHOU Hong-guang
Affiliation:Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China,Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China,Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China,Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China,Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China,Zhangjiagang First People''s Hospital, Zhangjiagang 215600, China,Jurong Hospital of TCM, Jurong 212400, China,Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China,Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China and Jiangsu Collaborative Innovation Center of Tumor Prevention and Treatment with Traditional Chinese Medicine(TCM), Nanjing University of Chinese Medicine, Nanjing 210023, China;Jiangsu Province Hospital of TCM, Nanjing 210029, China
Abstract:Objective: To study the effect of Xiaoai Jiedu formula on the proliferation of human hepatocarcinoma SMMC-7721 cells and expression profiles of microRNA(miR)-25-3p, miR-29a-5p, miR-122-3p, miR-124-3p and miR-182-5p. Method: Twelve male white rabbits were randomly divided into four groups. They were respectively given high-dose, middle-dose and low-dose Xiaoai Jiedu formula or normal saline for four days. Serum was taken from their carotid blood and then made into culture medium. Cytotoxicity of Xiaoai Jiedu formula against SMMC-7721 cells was measured by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay. Expression profiles of miR-25-3p, miR-29a-5p, miR-122-3p, miR-124-3p and miR-182-5p of SMMC-7721 cells were analyzed by a miRNA array and Real-time polymerase chain reaction (Real-time PCR). Result: High-dose, middle-dose and low-dose Xiaoai Jiedu formula could all inhibit the proliferation of SMMC-7721 cells after 12, 24, 48 h. Xiaoai Jiedu formula gradually increased the proliferation inhibition rate of SMMC-7721 cells in a dose-dependent manner, with the increase of drug concentration. The absorbancy of the high-dose group showed statistical differences after 12 h and 48 h compared with blank control group at the same time points (P<0.05). The absorbancy of the high-dose group showed statistically significant differences after 24 h compared with the blank control group at the same time point (P<0.01). The absorbancy of the high dose group after intervention for 24 h was significantly lower than that of blank control group (P<0.01), the group''s inhibition rate was 42.86%. Moreover, Real-time PCR verified the down-regulation of miR-25-3p, miR-182-5p and the up-regulation of miR-29a-5p, miR-122-3p, miR-124-3p induced by Xiaoai Jiedu formula. The regulatory effect of the high-dose group was more significant than that of the blank control group (P<0.01). Conclusion: Xiaoai Jiedu formula may inhibit the proliferation of SMMC-721 by inducing the change in microRNA (miRNA) expression. However, the concrete mechanism remains to be further studied.
Keywords:cancerous toxin  Xiaoai Jiedu formula  hepatocarcinoma SMMC-7721 cell  microRNA  proliferation inhibition
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号